Moderna (MRNA) Announces UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of mRNA Vaccine Against COVID-19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Moderna (MRNA) Announces UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of mRNA Vaccine Against COVID-19

UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)

October 27, 2020 9:00 AM EDT

Moderna completed enrollment of its Phase 3 COVE study of mRNA-1273 on October 22

Rolling review based on preclinical, CMC, and clinical data available to date

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to... More